| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |